期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

蒽环类抗肿瘤药物心脏毒性研究进展 被引量：6

Research progress of cardiotoxicology of anthracycline chemotherapeutics
下载PDF
导出
摘要 蒽环类药物是最常用的、疗效确切的抗癌药之一,其最显著和常见的副反应是心脏毒性,本文对该类药物心脏毒性临床表现、发生机制、危险因素及防治措施进行综述. Anthracyclines are one of the most commonly used and exactly curative effect anticancer drugs,but their most significantly and frequently adverse reaction is cardiotoxicology.This review summarized the clinicl features,mechanisms,risk factors and prevent measures of cardiotoxicology of anthracycline chemotherapeutics.
作者 俞淑文 张宁 邱丽筠 崔慧斐 王凤山
机构地区 山东大学药学院生化与生物技术药物研究所 山东大学附属济南市中心医院
出处 《齐鲁药事》 2010年第12期738-740,共3页 qilu pharmaceutical affairs
关键词 蒽环类药物 心脏毒性 Anthracycline Cardiotoxicology
分类号 R979.14 [医药卫生—药品]
  • 相关文献

参考文献19

  • 1邵维维,邵宗鸿.蒽环类药物的心脏毒性及防治进展[J].中国实用内科杂志,2008,28(9):779-781. 被引量：34
  • 2覃玉桃,钟进才.阿霉素心肌病及其检测[J].临床荟萃,2000,15(24):1138-1139. 被引量：13
  • 3Swain SM,Whaley FS,Ewer MS.Congestive heart failure in patients treated with doxorubicin:a retrospective analysis of three trials[J].Cancer,2003,97(11):2869-2879.
  • 4张竞竞,孙惠娟.蒽环类抗肿瘤药物的心脏毒性[J].临床肺科杂志,2008,13(3):325-326. 被引量：22
  • 5张明岩,安晶红,柴淼,潘宇,袁国明.阿霉素在临床应用中心脏毒性的研究进展[J].哈尔滨医药,2008,28(5):55-56. 被引量：6
  • 6Fisher PW,Salloum F,Das A,et al.Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardio-toxicity[J].Circulation,2005,111(13):1601-1610.
  • 7Cusack B J,Gambliel H,Musser B,et al.Prevention of chronic anthracycline cardio toxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism[J].Cancer Chemother Pharmacol,2006,58(4):517-526.
  • 8Faure H,Coudray C,Mousseau M,et al.5-Hydroxymethyluracil excretion,plasma TBARS and plasma antioxidant vitamins in adriamycin-treated patients[J].Free Radic Biol Med,1996,20 (7):979-983.
  • 9Kim S Y,Kim S J,Kim B J,et al.Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes[J].Exp Mol Med,2006,38(5):535-545.
  • 10Santos DL,Moreno AJ,Leino RL,et al.Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy[J].Toxicol Appl Pharmacol,2002,185(3):218-227.

二级参考文献34

  • 1李玉升,储大同.癌治疗出现的心脏问题[J].实用肿瘤杂志,1995,10(3):188-189. 被引量：8
  • 2李素英,刘运德.阿霉素的心脏毒副作用及其防治[J].心血管病学进展,1995,16(1):38-39. 被引量：3
  • 3王书杰,武永吉,沈悌.蒽环类药物的心脏毒性[J].医学研究杂志,2006,35(1):64-66. 被引量：36
  • 4王根菊,韩国荣.Amifostine在肿瘤化疗中作用的研究进展[J].东南大学学报（医学版）,2006,25(2):139-142. 被引量：7
  • 5李文瑜,费洪文,陆泽生.无创监测表阿霉素心脏毒性-组织多普勒超声心动图[J].中国病理生理杂志,2006,22(10):1983-1986. 被引量：20
  • 6Germanakis I, Kalmanti M, Parthenakis F, et al. Correlation of plasma N-terminal pro-brain natriuretic peptide level with left ventricle mass in children treated with anthracyclines[ J]. Int J Cardiol,2006,108:212 -215.
  • 7Malty M, Espie M, Llombart A, et al. Muhicenter randomized Phase Ⅲ study of the cardioprotective effect of dexrazoxane in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy[ J]. Ann Onco1,2006 ,17 :614 - 622.
  • 8Sterba M, Popelova O, Simunek T, et al. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH) [ J ]. Toxicology ,2007,253 ( 3 ) : 150 - 166.
  • 9Kaiserva H, Simunek T, van der Vijgh W J, et al. Flavonoids as protectors against doxorubicin cardiotoxicity : role of iron chelation, an-tioxidant activity and inhibition of carbonyl reductase [ J ]. Biochim Biophys Acta,2007,1772 : 1065 - 1074.
  • 10Takemura G, Fujiwara H. Doxorubicin-induced cardiomyopathy from the eardiotoxic mechanisms to management[ J], Prag Cardiovase Dis,2007,49 (5) :330 - 352.

共引文献89

同被引文献42

引证文献6

二级引证文献35

齐鲁药事
2010年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部